37 Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer (AOC): long-term efficacy results

G.Aravantinos; G.Fountzlias; P.Kosmidis; Ma.Dimopoulos; Gp.Stathopoulos; N.Pavildis; D.Bafaloukos; S.Rigatos; S.Karpathios; Dv.Skarlos

首页> 外文期刊>European Journal of Cancer Supplements >37 Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer (AOC): long-term efficacy results

【24h】

37 Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer (AOC): long-term efficacy results

机译：37紫杉醇加卡铂与紫杉醇加交替卡铂和顺铂治疗晚期卵巢癌（AOC）的初步疗效：长期疗效

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共1页
作者
G.Aravantinos; G.Fountzlias; P.Kosmidis; Ma.Dimopoulos; Gp.Stathopoulos; N.Pavildis; D.Bafaloukos; S.Rigatos; S.Karpathios; Dv.Skarlos;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 37 Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer (AOC): long-term efficacy results [J] . G.Aravantinos, G.Fountzlias, P.Kosmidis, European Journal of Cancer Supplements . 2003,第5期

机译：37紫杉醇加卡铂与紫杉醇加交替卡铂和顺铂治疗晚期卵巢癌（AOC）的初步疗效：长期疗效
2. Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study. [J] . Aravantinos G, Fountzilas G, Kosmidis P, Annals of oncology: official journal of the European Society for Medical Oncology . 2005,第7期

机译：紫杉醇加卡铂与紫杉醇加交替卡铂和顺铂在晚期卵巢癌的初始治疗中的长期疗效：希腊合作肿瘤小组（HeCOG）的研究。
3. 915 POSTER Paclitaxel/carboplatin (TC) versus paclitaxel/carboplatin followed by topotecan (TOP) in first line treatment of advanced ovarian cancer. mature results of a gynecologic cancer interGroup (GCIG) phase III trial of the AGO OVAR and GINECO [J] . European Journal of Cancer Supplements . 2005,第2期

机译：915海报在晚期卵巢癌的一线治疗中，紫杉醇/卡铂（TC）与紫杉醇/卡铂，然后是拓扑替康（TOP）。 AGO OVAR和GINECO的妇科癌症间研究小组（GCIG）III期临床试验的结果
4. Anaphylactic and Anaphylactoid Reactions to Paclitaxel, Carboplatin, and Doxorubicin: Treatment with Rapid Desensitization [C] . N.M. Tennant, K. Keenan, U.A. Matulonis, Collegium Internationale Allergologicum . 2007

机译：对紫杉醇，卡铂和多柔比星的过敏性和过敏反应：快速脱敏的处理
5. Cost-Benefit Analysis of Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel for the Treatment of Metastatic Breast Cancer in the United States [D] . Vichansavakul, Kittaya 2013

机译：纳米白蛋白结合紫杉醇与溶剂型紫杉醇在美国治疗转移性乳腺癌的成本效益分析
6. Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases [O] . Yue-Ya Li, Chan Zhou, Deng-Xia Yang, 2015

机译：紫杉醇-依托泊苷-卡铂/顺铂与依托泊苷-卡铂/顺铂一线治疗合并小细胞肺癌：62例回顾性分析
7. Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel [O] . P. Hoskins, I. Vergote, A. Cervantes, 2010

机译：先进的卵巢癌：III期随机研究顺铂 - 拓扑替替康和卡铂 - 紫杉醇与Carboplatin-PACLitaxel

37 Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer (AOC): long-term efficacy results

著录项

相似文献

相关主题

期刊订阅